A meeting of the Advisory Committee on Medicines Scheduling (ACMS).
Members
The committee members are professionals with specific scientific, medical or clinical expertise, or expertise in consumer health issues relating to medicines.
Pre-meeting notice
For the pre-meeting public consultation notice go to:
Outcomes
-
Scheduling decisions (final)Final decisions on proposed amendments to the Poisons Standard relating to MDMA and psilocybin.
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 3 February 2021
-
Scheduling decisions (final)Notice of final decisions to amend the Poisons Standard - ACMS #32, Joint ACMS-ACCS #26, ACCS #29 (November 2020).